Navigation Links
Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells

Comparison of liposome-based transfection reagents


D.J. Lowrie Jr.
Department of Cell Biology, Neurobiology, and Anatomy
University of Cincinnati College of Medicine, Cincinnati, OH 45267


Transfection of mammalian cell lines is enhanced by the use of liposome-based reagents. Here we compare the transfection efficiency of green fluorescent protein into human adrenalcarcinoma cells using both LipoTAXI transfection reagent and LipofectAMINE reagent.

Our lab has recently been interested in the transient transfection of green fluorescent proteins into mammalian cells. We have been using the pEGFP-C3 and pEGFP-N3 vectors, which contain sequences encoding the enhanced version of green fluorescent protein (EGFP) whose expression is driven by the cytomegalovirus (CMV) promoter. Convenient restriction sites in these vectors allow fusion of a protein of interest to either the amino- or carboxy-terminus of EGFP.

The cell line used for many of our experiments is the human adrenalcarcinoma cell line, SW13, which contains vimentin intermediate filaments. A subclone derived from this cell line lacks vimentin expression and is thought to contain no intermediate filament network.1 Although we have previously had success using this cell line for transfection studies using calcium phosphate,2,3 two recent observations have led us to look for new methods that would improve our efficiency. First, we have found that some of our constructs have produced lower transfection efficiencies than others, making it difficult to obtain a suitable number of transfected cells to draw conclusions. Second, we have noticed heterogeneous subcellular localization of some of our fusion proteins in the same set of transfected cells. Presumably, this is due to varying levels of expression of exogenous proteins typical of transiently transfected cells. It was therefore necessary to optimize our transfection experiments in order to produce enough positively transfected cells for data analysis. In an attempt to overcome these difficulties, we compared the effectiveness of two liposome-based transfection reagents in SW13 cells using pEGFP-C3 as a control vector.

Transient Transfection of the pEGFP-C3 Vector into SW13 Cells

SW13 cells (8 x 104) were plated in a 24-well culture dish and allowed to attach overnight so that the cell density was between 60% and 80% confluent. In order to compare the relative efficiencies of the two liposome-mediated reagents, we used the manufacturers recommendations for concentration of reagent and DNA as a starting point for our experiments. Additional transfections were performed that used more or less of either the reagent or DNA. All procedures were performed according to the manufacturers recommendations, including the use of serum-free media for LipofectAMINE reagent-mediated transfections and serum-enriched media when adding LipoTAXI transfection reagent and DNA solutions to SW13 cells. Cells were exposed to the DNA-liposome complex for 5 hours at 37C in a humidified incubator with 5% CO2. Serum-containing medium was added to the cells, and the cells were incubated overnight. Cells were then fixed with 4% paraformaldehyde at room temperature for 25 minutes and rinsed with deionized, distilled water. Coverslips with attached cells were mounted in glycerol containing 2.5% 1,4-diazabicyclo(2.2.2)octane (DABCO) then viewed and photographed using a Nikon Microphot FX light microscope. Transfection efficiency was determined by counting fluorescent and total cells from six random fields for each condition.

Figure 1 shows fluorescent images of cells transfected under optimal conditions for either LipofectAMINE or LipoTAXI transfection reagents.4 Under all conditions tested, LipoTAXI transfection reagent was significantly more effective in transfecting the pEGFP-C3 vector into SW13 cells than LipofectAMINE reagent. Quantitative analysis of transfection efficiencies using various conditions for both liposome-based reagents is summarized in figure 2.

Figure 2

The increased transfection efficiency seen when using LipoTAXI transfection reagent creates a population of cells with various levels of exogenous protein expression. For some of our constructs, we have seen that expression level has a significant effect on the subcellular distribution of the exogenous protein (unpublished observations). Other effects of exogenous proteins, such as enzyme activity, may also be dependent on expression level. Use of LipoTAXI reagent provides a population of transfected cells containing diverse levels of expression of exogenous protein that may enhance studies.

We have concluded that LipoTAXI transfection reagent is less toxic to cells than LipofectAMINE reagent. This conclusion is based on our observation that cell death, as indicated by floating cells, occurred with greater frequency with increasing concentrations of LipofectAMINE reagent. This effect was not seen with increasing concentrations of LipoTAXI reagent. In addition, cell death was much more pronounced in areas where cell density was lower than 50%. This observation may be important for investigators who perform transfections with cell populations that are below confluency, such as those studying cell-cell adhesion.

Conclusions

Our results show that LipoTAXI transfection reagent is significantly more effective than LipofectAMINE reagent for transfecting enhanced green fluorescent protein into SW13 cells. Furthermore, LipoTAXI transfection reagent was effective over a broader range of conditions than LipofectAMINE reagent. Because of the low toxicity and increased efficiency of LipoTAXI transfection reagent, it is an invaluable tool for research that is dependent on a higher number of transfected cells in the total cell population.

REFERENCES
  1. Sarria, A.J., et al. (1990) J. Cell Biol. 111: 553-565.

  2. Makarova, I., et al. (1994) Cell Motil. Cytoskeleton 28: 265-277.

  3. Sambrook, J., et al. (1989) In Molecular Cloning. A Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.

  4. Pingerelli, P., Petre, M. (1997), and Karmiol, S. Strategies 10: 8-9.


'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
2. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
3. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
4. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
5. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
6. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
7. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
8. Efficient Transfection of Neurospora Crassa
9. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
10. Efficient Transfection of Neurospora Crassa
11. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
Post Your Comments:
(Date:7/2/2015)... July 2, 2015 Amici Procurement ... procurement company Amici Procurement has chosen Microsoft Cloud Solution ... move to Office 365.      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) ... to medium-sized companies in the bio-tech sector with a ... the purchasing cycle to help them obtain best value. ...
(Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
(Date:7/1/2015)... ... July 01, 2015 , ... The next-generation sequencing (NGS) clinical market is ... the molecular diagnostics industry. BCC Research reveals in its new report that the market ... costs, and a growing need for better diagnostics as part of a molecular diagnostics ...
(Date:7/1/2015)... Bermuda , July 1, 2015  Axovant ... company focused on the treatment of dementia, today ... briefing on July 22 at 5:45 p.m. EDT ... the Alzheimer,s Association International Conference 2015 (AAIC). ... remarks: , Dr. Lawrence Friedhoff ...
Breaking Biology Technology:Biotech Procurement Company Moves to Office 365 with iomart 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
... leader in providing automated, molecular testing solutions announced today ... Food and Drug Administration to market its INFINITI® CYP2C19 ... *17, of the CYP450 2C19 gene and is to ... the INFINITI® Analyzer.   "We are very ...
... (Nasdaq: OPTR ) is scheduled to present ... Hotel in New York City on Tuesday, November 2, ... http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO ) ... be accessible on the Company,s website at www.optimerpharma.com ...
... DIEGO, Oct. 26 aTyr Pharma, the physiocrine ... C equity financing led by Domain Associates.  Domain ... and Polaris Ventures, who also participated in the ... development of aTyr,s preclinical pipeline and advance physiocrine ...
Cached Biology Technology:AutoGenomics Receives FDA Clearance for its INFINITI® CYP2C19 Assay 2Optimer Pharmaceuticals to Present at Oppenheimer Healthcare Conference 2aTyr Pharma Secures $23M Financing From Top Tier Venture Investor 2
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ... Generation Biometrics Market by Application, Technology, Function & Geography ... offering. The next generation biometrics market is ... CAGR of 17.9% between 2015 and 2020 ... market. Safran SA ( France ...
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
(Date:6/29/2015)... , June 24, 2015 ... addition of the "Latin America Biomedical Sensors Market ... their offering. The Latin America Biomedical Sensors ... a CAGR of 2.04% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2
... What influence does the variation in estrogen level ... Using functional Magnetic Resonance Imaging, Jean-Claude Dreher, a ... 1), in collaboration with an American team from ... directed by Karen Berman, has identified, for the ...
... worldwide influenza pandemic caused by mutation of a bird-specific ... infectious avian strain has caused outbreaks of bird flu ... virus might also mutate to allow human-to-human transmission and ... protein, the polymerase, contribute to the ability of the ...
... by Dr. John Dick at Ontario Cancer Institute (OCI) have ... "human" leukemia stem cells. The converted cells, when transplanted ... can replicate the entire disease process from the very moment ... , Dr. Dick, Senior Scientist at OCI, the research ...
Cached Biology News:The influence of the menstrual cycle on the female brain 2The influence of the menstrual cycle on the female brain 3The influence of the menstrual cycle on the female brain 4A first glimpse of the influenza replication machine 2Cancer scientists create 'human' leukemia process to map how disease begins, progresses 2
Anti-NCAPD3 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunoprecipitation, Western Blot...
...
...
BD Falcon microtest assay plate. 1536 well 12l, black, flat-bottom PS. Polystyrene, nonsterile, no lid. (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
Biology Products: